• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性淋巴细胞白血病/小淋巴细胞淋巴瘤(CLL/SLL)患者自杀风险评估与预测模型

Risk assessment and predictive modeling of suicide in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Patients.

作者信息

Wang Fan

机构信息

Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, The People's Republic of China.

出版信息

J Cancer Surviv. 2025 May 28. doi: 10.1007/s11764-025-01839-9.

DOI:10.1007/s11764-025-01839-9
PMID:40437211
Abstract

BACKGROUND

Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) predominantly affects older adults and is characterized by a prolonged disease course. While overall survival has improved, the psychosocial burden, including suicide risk, remains underexplored.​ METHODS: A retrospective cohort study was conducted using data from 95,517 patients diagnosed with CLL/SLL between 2000 and 2021 from the SEER 17 registry. LASSO regression was utilized for variable selection, followed by univariate and multivariate Cox proportional hazards and Fine-Gray competing risk analyses to identify independent predictors. A nomogram was developed based on significant predictors and validated using time-dependent receiver operating characteristic (ROC) curves, calibration plots, and decision curve analysis (DCA).​ RESULTS: The cohort's mean age was 69.2 years, with 21.6% aged ≥ 80 years and a male-to-female ratio of 1.5:1; 88.8% were White. Although the suicide rate was low (0.1%), multivariate analysis showed that male sex, non-married status, lower income, and White race were significantly associated with increased suicide risk. Advanced age (≥ 80) was significant in Cox but not in competing risk models. The nomogram demonstrated good predictive accuracy (AUC > 0.71 at 3, 5, and 10 years) and clinical utility.

CONCLUSIONS

Sociodemographic factors, including sex, race, marital status, and income, are independently associated with suicide risk in CLL/SLL patients. The developed nomogram offers a practical, evidence-based tool for early identification of high-risk individuals, thereby facilitating targeted psychosocial interventions and improving survivorship care.

IMPLICATIONS FOR CANCER SURVIVORS

CLL/SLL survivors who are male, unmarried, or of lower socioeconomic status face heightened suicide risk, highlighting the critical need for tailored psychosocial support within survivorship care.

摘要

背景

慢性淋巴细胞白血病/小淋巴细胞淋巴瘤(CLL/SLL)主要影响老年人,其病程较长。虽然总体生存率有所提高,但包括自杀风险在内的心理社会负担仍未得到充分研究。

方法

利用监测、流行病学和最终结果(SEER)17登记处2000年至2021年间诊断为CLL/SLL的95517例患者的数据进行回顾性队列研究。采用套索回归进行变量选择,随后进行单变量和多变量Cox比例风险分析以及Fine-Gray竞争风险分析,以确定独立预测因素。基于显著预测因素开发了列线图,并使用时间依赖性受试者工作特征(ROC)曲线、校准图和决策曲线分析(DCA)进行验证。

结果

该队列的平均年龄为69.2岁,其中21.6%的患者年龄≥80岁,男女比例为1.5:1;88.8%为白人。虽然自杀率较低(0.1%),但多变量分析显示,男性、未婚状态、低收入和白人种族与自杀风险增加显著相关。高龄(≥80岁)在Cox模型中具有显著性,但在竞争风险模型中不显著。列线图显示出良好的预测准确性(3年、5年和10年时的AUC>0.71)和临床实用性。

结论

社会人口学因素,包括性别、种族、婚姻状况和收入,与CLL/SLL患者的自杀风险独立相关。所开发的列线图为早期识别高危个体提供了一种实用的、基于证据的工具,从而有助于进行有针对性的心理社会干预并改善生存护理。

对癌症幸存者的启示

男性、未婚或社会经济地位较低的CLL/SLL幸存者面临更高的自杀风险,这凸显了在生存护理中提供量身定制的心理社会支持的迫切需求。

相似文献

1
Risk assessment and predictive modeling of suicide in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Patients.慢性淋巴细胞白血病/小淋巴细胞淋巴瘤(CLL/SLL)患者自杀风险评估与预测模型
J Cancer Surviv. 2025 May 28. doi: 10.1007/s11764-025-01839-9.
2
Racial differences in the presentation and outcomes of chronic lymphocytic leukemia and variants in the United States.美国慢性淋巴细胞白血病及其变异在临床表现和结局方面的种族差异。
Clin Lymphoma Myeloma Leuk. 2011 Dec;11(6):498-506. doi: 10.1016/j.clml.2011.07.002. Epub 2011 Sep 1.
3
Outcomes of Richter's transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): an analysis of the SEER database.里希特转化型慢性淋巴细胞白血病/小淋巴细胞淋巴瘤(CLL/SLL)的结局:SEER 数据库分析。
Ann Hematol. 2021 Oct;100(10):2513-2519. doi: 10.1007/s00277-021-04603-y. Epub 2021 Jul 19.
4
Medication Adherence, Health Care Utilization, and Costs Among Patients Initiating Oral Oncolytics for Multiple Myeloma or Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.口服肿瘤药物治疗多发性骨髓瘤或慢性淋巴细胞白血病/小淋巴细胞淋巴瘤患者的药物依从性、医疗保健利用和成本。
J Manag Care Spec Pharm. 2020 Feb;26(2):186-196. doi: 10.18553/jmcp.2020.26.2.186.
5
Monoclonal B-cell lymphocytosis in the bone marrow: revisiting the criteria for chronic lymphocytic leukemia/small lymphocytic lymphoma.骨髓中单克隆 B 细胞淋巴增生:重新审视慢性淋巴细胞白血病/小淋巴细胞淋巴瘤的标准。
Hum Pathol. 2022 Jul;125:108-116. doi: 10.1016/j.humpath.2022.04.010. Epub 2022 Apr 25.
6
Healthcare resource utilization and costs of chronic lymphocytic leukemia/small lymphocytic lymphoma patients who relapse or are refractory to ibrutinib.伊布替尼治疗后复发或耐药的慢性淋巴细胞白血病/小淋巴细胞淋巴瘤患者的医疗资源利用和成本。
Future Oncol. 2024;20(35):2723-2735. doi: 10.1080/14796694.2024.2390351. Epub 2024 Oct 7.
7
Primary cutaneous lymphomas in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): A series of 12 cases.慢性淋巴细胞白血病/小淋巴细胞淋巴瘤(CLL/SLL)患者的原发性皮肤淋巴瘤:系列 12 例。
J Cutan Pathol. 2021 May;48(5):617-624. doi: 10.1111/cup.13956. Epub 2021 Jan 23.
8
Mixed-methods research to support the use of new lymphoma-specific patient-reported symptom measures derived from the EORTC item library.支持使用源自 EORTC 项目库的新淋巴瘤特异性患者报告症状测量工具的混合方法研究。
J Patient Rep Outcomes. 2024 Jan 22;8(1):8. doi: 10.1186/s41687-024-00683-2.
9
Epidemiology, treatment patterns and survival of chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL) in Taiwan, 2006-2015.2006-2015 年台湾地区慢性淋巴细胞白血病/小淋巴细胞淋巴瘤(CLL/SLL)的流行病学、治疗模式和生存情况。
Int J Clin Pract. 2021 Aug;75(8):e14258. doi: 10.1111/ijcp.14258. Epub 2021 May 29.
10
Chronic lymphocytic leukaemia and small lymphocytic lymphoma: overview of the descriptive epidemiology.慢性淋巴细胞白血病和小淋巴细胞淋巴瘤:描述性流行病学概述
Br J Haematol. 2007 Dec;139(5):809-19. doi: 10.1111/j.1365-2141.2007.06856.x. Epub 2007 Oct 17.

本文引用的文献

1
Chronic Lymphocytic Leukemia: 2025 Update on the Epidemiology, Pathogenesis, Diagnosis, and Therapy.慢性淋巴细胞白血病:2025年流行病学、发病机制、诊断与治疗最新进展
Am J Hematol. 2025 Mar;100(3):450-480. doi: 10.1002/ajh.27546. Epub 2025 Jan 28.
2
Risk assessment and predictive modeling of suicide in multiple myeloma patients.多发性骨髓瘤患者自杀的风险评估与预测模型
J Cancer Surviv. 2024 Dec 17. doi: 10.1007/s11764-024-01732-x.
3
Suicide among lymphoma patients.淋巴瘤患者的自杀问题。
J Affect Disord. 2024 Sep 1;360:97-107. doi: 10.1016/j.jad.2024.05.158. Epub 2024 May 29.
4
Chronic Lymphocytic Leukemia: Time to Care for the Survivors.慢性淋巴细胞白血病:是时候关注幸存者了。
J Clin Oncol. 2024 Jun 10;42(17):2005-2011. doi: 10.1200/JCO.23.02738. Epub 2024 Mar 15.
5
BTK inhibitors in CLL: second-generation drugs and beyond.慢性淋巴细胞白血病中的 BTK 抑制剂:第二代药物及其他。
Blood Adv. 2024 May 14;8(9):2300-2309. doi: 10.1182/bloodadvances.2023012221.
6
Identifying the Risk Factors of Suicidal Ideation in Patients With Hematologic Malignancies Using a Multidimensional Approach.采用多维方法识别血液恶性肿瘤患者自杀意念的风险因素。
West J Nurs Res. 2024 Feb;46(2):81-89. doi: 10.1177/01939459231216870. Epub 2023 Dec 11.
7
Diagnosis and Treatment of Chronic Lymphocytic Leukemia: A Review.慢性淋巴细胞白血病的诊断与治疗:综述
JAMA. 2023 Mar 21;329(11):918-932. doi: 10.1001/jama.2023.1946.
8
Suicide Risk Among Individuals Diagnosed With Cancer in the US, 2000-2016.美国 2000-2016 年被诊断患有癌症的个体的自杀风险。
JAMA Netw Open. 2023 Jan 3;6(1):e2251863. doi: 10.1001/jamanetworkopen.2022.51863.
9
How we treat mature B-cell neoplasms (indolent B-cell lymphomas).我们如何治疗成熟 B 细胞肿瘤(惰性 B 细胞淋巴瘤)。
J Hematol Oncol. 2021 Jan 6;14(1):5. doi: 10.1186/s13045-020-01018-6.
10
Suicide among cancer patients.癌症患者的自杀问题。
Nat Commun. 2019 Jan 14;10(1):207. doi: 10.1038/s41467-018-08170-1.